ANDA 77981, held by Cipla. Zidovudine.
As of Nov 21, 2026, ANDA 77981 (Zidovudine), held by Cipla, was first approved by FDA on Jun 26, 2008, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 26, 2008 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Zidovudine50MG/5ML · solution;oral | Zidovudine | Discontinued |
| Sep 17, 2025 | Supplement 32Labeling · Standard review | Approved | None posted |
| Jan 8, 2019 | Supplement 28Labeling · Standard review | Approved | None posted |
| Jan 8, 2019 | Supplement 27Labeling · Standard review | Approved | None posted |
| Jan 8, 2019 | Supplement 26Labeling · Standard review | Approved | None posted |
| Jun 13, 2017 | Supplement 25Labeling · Standard review | Approved | None posted |
| Jun 13, 2017 | Supplement 24Labeling · Standard review | Approved | None posted |
| Jun 30, 2015 | Supplement 22Labeling · Standard review | Approved | None posted |
| Jun 30, 2015 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jun 30, 2015 | Supplement 19Labeling · Standard review | Approved | None posted |
| May 31, 2014 | Supplement 18Labeling | Approved | None posted |
| Nov 21, 2013 | Supplement 17Labeling · Standard review | Approved | None posted |
| Nov 21, 2013 | Supplement 16Labeling · Standard review | Approved | None posted |
| Jul 31, 2013 | Supplement 14Labeling · Standard review | Approved | None posted |
| Aug 9, 2012 | Supplement 11Labeling · Standard review | Approved | None posted |
| Aug 9, 2012 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jan 10, 2011 | Supplement 3Labeling | Approved | None posted |
| Jun 26, 2008 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters